| Line Item | 2026-04-05 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.6M | — | +49.1% |
| Cost of Revenue | $6.0M | — | +25.0% |
| Gross Profit | $1.6M | — | +494.6% |
| R&D Expense | $26.5M | — | +2.3% |
| SG&A Expense | $18.9M | — | +12.0% |
| Operating Income | -$43.9M | — | -3.1% |
| Interest Expense | $7.0M | — | +308.4% |
| Pre-tax Income | -$38.4M | — | -62.0% |
| Income Tax | -$129K | — | +20.4% |
| Net Income | -$38.3M | — | -62.7% |
| EPS (Basic) | -$0.18 | — | -50.0% |
| EPS (Diluted) | -$0.18 | — | -50.0% |
| Line Item | 2026-04-05 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $88.8M | -16.3% | -53.3% |
| Short-term Investments | $440.0M | +8.4% | +654.9% |
| Accounts Receivable | $3.9M | -10.8% | +36.1% |
| Inventory | $16.5M | +20.8% | +56.9% |
| Current Assets | $558.5M | +3.0% | +106.7% |
| Total Assets | $833.9M |
| Line Item | 2026-04-05 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$33.1M | — | -95.6% |
| Capital Expenditures | $3.2M | — | -48.7% |
| Investing Cash Flow | $18.3M | — | +128.5% |
| Financing Cash Flow | -$2.5M | — | -64.9% |
| Free Cash Flow | -$36.3M | — | -56.6% |
| +67.1% |
| Current Liabilities | $50.9M | -21.7% | -11.9% |
| Long-term Debt | $520.4M | +0.2% | +207.3% |
| Total Liabilities | $591.2M | -2.3% | +126.3% |
| Stockholders' Equity | $240.7M | -11.3% | +2.4% |